News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website


Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma

Al's Comment:

 This provides a great overview of the treatments being used for diffuse midline glioma and DIPG. It also talks about the use of a liquid biopsy to monitor tumor response.  Regular MRI scans are not conclusive when it comes to these tumors - parts of these tumors do not enhance and the edges are diffuse so it is hard to quantify how much tumor is there and if it is getting better or worse. A liquid biopsy might help!

Posted on: 02/18/2020

Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma


Click HERE to return to brain tumor news headlines

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557